Registrati | Log in | FAQ      [?] 
Recent | Unread | Search | Authors | Tags | Export

di jyuh hcc [40 articles]

Articoli aggiunti di recente alla biblioteca di jyuh classificati sotto il tag hcc. You can also see everyone's hcc.
  • The degree of readiness of selected biomarkers for the early detection of hepatocellular carcinoma: notes from a recent workshop.
    Cancer biomarkers : section A of Disease markers, Vol. 4, No. 1. (2008), pp. 19-33.
    by TM Block, J Marrero, RG Gish, M Sherman, WT London, S Srivastava, PD Wagner
    posted to hcc biomarker by jyuh on 2008-10-26 04:33:37 as **
  • A Quantitative Proteomic Approach for Identification of Potential Biomarkers in Hepatocellular Carcinoma
    J. Proteome Res. (21 August 2008)
    by Raghothama Chaerkady, HC Harsha, Anuradha Nalli, Marjan Gucek, Perumal Vivekanandan, Javed Akhtar, Robert N Cole, Jessica Simmers, Richard D Schulick, Sujay Singh, Michael Torbenson, Akhilesh Pandey, Paul J Thuluvath
    posted to proteomics hcc by jyuh on 2008-10-14 08:49:24 as ** along with 1 person brianb
  • Using proteomic approach to identify tumor-associated antigens as markers in hepatocellular carcinoma.
    Journal of proteome research, Vol. 7, No. 9. (September 2008), pp. 4004-4012.
    by KS Looi, ES Nakayasu, RA Diaz, EM Tan, IC Almeida, JY Zhang
    posted to proteomics hcc by jyuh on 2008-10-14 02:32:23 as **
  • Toward the proteomic identification of biomarkers for the prediction of HBV related hepatocellular carcinoma.
    Journal of cellular biochemistry, Vol. 103, No. 3. (15 February 2008), pp. 740-752.
    by QY He, R Zhu, T Lei, MY Ng, JM Luk, P Sham, GK Lau, JF Chiu
    posted to proteomics hcc by jyuh on 2008-10-14 02:29:53 as **
  • Oncoproteomics of hepatocellular carcinoma: from cancer markers' discovery to functional pathways
    Liver International, Vol. 27, No. 8. (October 2007), pp. 1021-1038.
    by Sun, Stella, Lee, PY Nikki, Poon, TP Ronnie, Fan, Sheung-Tat, He, Y Qing, Lau, K George, Luk, M John
    posted to proteomics hcc by jyuh on 2008-10-14 02:18:31 as **
  • High-dimensional biology to comprehend hepatocellular carcinoma
    Expert Review of Proteomics, Vol. 5, No. 1. (February 2008), pp. 45-60.
    by Vivekanandan, Perumal, Singh, V Om
    posted to microarray hcc genomics by jyuh on 2008-10-09 09:48:57 as ** along with 1 person frohike
  • Angiotensin II and epidermal growth factor receptor cross-talk mediated by a disintegrin and metalloprotease accelerates tumor cell proliferation of hepatocellular carcinoma cell lines.
    Hepatology research : the official journal of the Japan Society of Hepatology, Vol. 38, No. 6. (June 2008), pp. 601-613.
    by H Itabashi, C Maesawa, H Oikawa, K Kotani, E Sakurai, K Kato, H Komatsu, H Nitta, H Kawamura, G Wakabayashi, T Masuda
    posted to hcc egfr aii adam by jyuh on 2008-10-05 17:16:16 as **
  • Quantitative analysis of circulating methylated DNA as a biomarker for hepatocellular carcinoma.
    Clinical chemistry, Vol. 54, No. 9. (September 2008), pp. 1528-1536.
    by KC Chan, PB Lai, TS Mok, HL Chan, C Ding, SW Yeung, YM Lo
    posted to methylation hcc blood by jyuh on 2008-09-29 10:40:33 as **
  • Liver regeneration and tumor stimulation--a review of cytokine and angiogenic factors.
    Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, Vol. 12, No. 5. (May 2008), pp. 966-980.
    by C Christophi, N Harun, T Fifis
    posted to liver-regneration hcc cytokine by jyuh on 2008-09-27 06:59:49 as **
  • Regulation of liver regeneration and hepatocarcinogenesis by suppressor of cytokine signaling 3.
    The Journal of experimental medicine, Vol. 205, No. 1. (21 January 2008), pp. 91-103.
    by KJ Riehle, JS Campbell, RS McMahan, MM Johnson, RP Beyer, TK Bammler, N Fausto
    posted to socs hcc by jyuh on 2008-09-27 06:56:01 as **
  • SOCS3 in liver regeneration and hepatocarcinoma.
    Molecular interventions, Vol. 8, No. 1. (February 2008)
    by J Elliott
    posted to socs hcc by jyuh on 2008-09-27 06:55:41 as **
  • Thalidomide in advanced hepatocellular carcinoma as antiangiogenic treatment approach: a phase I/II trial.
    European journal of gastroenterology & hepatology, Vol. 20, No. 10. (October 2008), pp. 1012-1019.
    by M Pinter, M Wichlas, K Schmid, C Plank, C Müller, F Wrba, M Peck-Radosavljevic
    posted to thalidomide hcc by jyuh on 2008-09-27 05:06:17 as **
  • Growth factors as therapeutic targets in HCC.
    Critical reviews in oncology/hematology, Vol. 67, No. 1. (July 2008), pp. 8-15.
    by J Furuse
    posted to vegf pdgf inhibitor hcc by jyuh on 2008-09-27 05:05:50 as **
  • From molecular biology to targeted therapies for hepatocellular carcinoma: the future is now.
    Oncology, Vol. 72 Suppl 1 (2007), pp. 30-44.
    by RW Pang, RT Poon
    posted to vegf pdgf hcc by jyuh on 2008-09-27 05:05:35 as **
  • Sorafenib in advanced hepatocellular carcinoma.
    The New England journal of medicine, Vol. 359, No. 4. (24 July 2008), pp. 378-390.
    by JM Llovet, S Ricci, V Mazzaferro, P Hilgard, E Gane, JF Blanc, AC de Oliveira, A Santoro, JL Raoul, A Forner, M Schwartz, C Porta, S Zeuzem, L Bolondi, TF Greten, PR Galle, JF Seitz, I Borbath, D Häussinger, T Giannaris, M Shan, M Moscovici, D Voliotis, J Bruix,
    posted to vegf pdgf inhibitor hcc by jyuh on 2008-09-27 05:04:09 as ** along with 1 person djmonstermo
  • Hepatocellular carcinoma: current management and recent advances.
    Hepatobiliary & pancreatic diseases international : HBPD INT, Vol. 7, No. 3. (June 2008), pp. 237-257.
    by WY Lau, EC Lai
    posted to treatment hcc by jyuh on 2008-09-27 05:01:20 as **
  • Review article: pharmacological therapy of hepatocellular carcinoma with sorafenib and other oral agents.
    Alimentary pharmacology & therapeutics (20 September 2008)
    by M Chaparro, L González Moreno, M Trapero-Marugán, J Medina, R Moreno-Otero
    posted to vegf pdgf inhibitor hcc by jyuh on 2008-09-27 04:59:53 as **
  • Development of sorafenib and other molecularly targeted agents in hepatocellular carcinoma.
    Cancer, Vol. 112, No. 2. (15 January 2008), pp. 250-259.
    by AX Zhu
    posted to vegf pdgf inhibitor hcc by jyuh on 2008-09-27 04:59:41 as **
  • Caffeine Inhibits the Proliferation of Liver Cancer Cells and Activates the MEK/ERK/EGFR Signalling Pathway
    Basic & Clinical Pharmacology & Toxicology, Vol. 102, No. 6. (June 2008), pp. 543-551.
    by Okano, Jun-Ichi, Nagahara, Takakazu, Matsumoto, Kazuya, Murawaki, Yoshikazu
    posted to hcc erk egfr coffee by jyuh on 2008-09-27 04:57:10 as **
  • Associations Between Hepatitis B Virus Genotype and Mutants and the Risk of Hepatocellular Carcinoma
    J. Natl. Cancer Inst. (11 August 2008), djn243.
    by Hwai-I Yang, Shiou-Hwei Yeh, Pei-Jer Chen, Uchenna H Iloeje, Chin-Lan Jen, Jun Su, Li-Yu Wang, Sheng-Nan Lu, San-Lin You, Ding-Shinn Chen, Yun-Fan Liaw, Chien-Jen Chen, For
    posted to tw genomics hbv hcc by jyuh on 2008-08-26 10:56:00 as ** along with 1 person DarsDakota
  • Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan.
    Gastroenterology, Vol. 135, No. 1. (July 2008), pp. 111-121.
    by CL Chen, HI Yang, WS Yang, CJ Liu, PJ Chen, SL You, LY Wang, CA Sun, SN Lu, DS Chen, CJ Chen
    posted to tw hbv hcc hcv by jyuh on 2008-08-26 10:55:13 as **
  • Long-term tracking of hepatitis B viral load and the relationship with risk for hepatocellular carcinoma in men.
    Carcinogenesis, Vol. 29, No. 1. (January 2008), pp. 106-112.
    by CF Wu, MW Yu, CL Lin, CJ Liu, WL Shih, KS Tsai, CJ Chen
    posted to tw hbv hcc by jyuh on 2008-08-26 10:54:59 as **
  • Impact of chewing betel-nut (Areca catechu) on liver cirrhosis and hepatocellular carcinoma: a population-based study from an area with a high prevalence of hepatitis B and C infections.
    Public health nutrition (15 April 2008), pp. 1-7.
    by Grace Hui-Min H Wu, Barbara J J Boucher, Yueh-Hsia H Chiu, Chao-Sheng S Liao, Tony Hsiu-Hsi H Chen
    posted to tw lc hcc betel by jyuh on 2008-08-23 15:18:32 as **
  • Transforming growth factor-beta gene expression signature in mouse hepatocytes predicts clinical outcome in human cancer.
    Hepatology (Baltimore, Md.), Vol. 47, No. 6. (June 2008), pp. 2059-2067.
    by C Coulouarn, VM Factor, SS Thorgeirsson
    posted to hcc hepatotyte tgfb by jyuh on 2008-08-19 03:10:04 as **
  • Inflammation, HCC and sex: IL-6 in the centre of the triangle.
    Journal of hepatology, Vol. 48, No. 2. (February 2008), pp. 380-381.
    by J Prieto
    posted to gender hcc il6 by jyuh on 2008-08-17 01:54:35 as **
  • Modeling liver cancer using zebrafish: a comparative oncogenomics approach.
    Cell cycle (Georgetown, Tex.), Vol. 5, No. 6. (March 2006), pp. 573-577.
    by SH Lam, Z Gong
    posted to hcc zebrafish by jyuh on 2008-08-09 04:50:50 as **
  • Genistein arrests hepatoma cells at G2/M phase: involvement of ATM activation and upregulation of p21waf1/cip1 and Wee1.
    Biochemical pharmacology, Vol. 67, No. 4. (15 February 2004), pp. 717-726.
    by KL Chang, ML Kung, NH Chow, SJ Su
    posted to tw atm hcc herb p21 by jyuh on 2008-07-21 12:13:13 as **
  • Sorafenib: in hepatocellular carcinoma.
    Drugs, Vol. 68, No. 2. (2008), pp. 251-258.
    by D Simpson, GM Keating
    posted to vegf treatment pdgf inhibitor hcc by jyuh on 2008-07-19 17:13:41 as **
  • MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma.
    Hepatology (Baltimore, Md.), Vol. 47, No. 4. (April 2008), pp. 1223-1232.
    by H Varnholt, U Drebber, F Schulze, I Wedemeyer, P Schirmacher, HP Dienes, M Odenthal
    posted to hcc hcv mirna by jyuh on 2008-07-14 04:46:33 as **
  • Activation of hepatic stem cell marker EpCAM by Wnt-beta-catenin signaling in hepatocellular carcinoma.
    Cancer research, Vol. 67, No. 22. (15 November 2007), pp. 10831-10839.
    by T Yamashita, A Budhu, M Forgues, XW Wang
    posted to catenin hcc liver stem-cell wnt by jyuh on 2008-07-03 06:51:22 as **
  • Hepatocellular Carcinoma
    Disease-a-Month, Vol. 54, No. 7. (July 2008), pp. 432-444.
    by Willscott E Naugler, Jonathan M Schwartz
    posted to hcc by jyuh on 2008-06-29 09:13:18 as **
  • Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis.
    Health technology assessment (Winchester, England), Vol. 11, No. 34. (September 2007), pp. 1-206.
    by J Thompson Coon, G Rogers, P Hewson, D Wright, R Anderson, M Cramp, S Jackson, S Ryder, A Price, K Stein
    posted to cea hcc lc meta-analysis by jyuh on 2008-06-13 05:44:36 as **
  • Surgical treatment of hepatocellular carcinoma: evidence-based outcomes.
    World journal of gastroenterology : WJG, Vol. 14, No. 5. (7 February 2008), pp. 685-692.
    by S Yamazaki, T Takayama
    posted to hcc surgery by jyuh on 2008-06-11 09:48:44 as **
  • Design and endpoints of clinical trials in hepatocellular carcinoma.
    Journal of the National Cancer Institute, Vol. 100, No. 10. (21 May 2008), pp. 698-711.
    by JM Llovet, AM Di Bisceglie, J Bruix, BS Kramer, R Lencioni, AX Zhu, M Sherman, M Schwartz, M Lotze, J Talwalkar, GJ Gores,
    posted to endpoint hcc rct by jyuh on 2008-06-09 11:15:07 as **
  • Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus.
    Hepatology (Baltimore, Md.), Vol. 47, No. 6. (1 February 2008), pp. 1856-1862.
    by Bart J J Veldt, Wendong Chen, E Jenny J Heathcote, Heiner Wedemeyer, Juerg Reichen, W Peter P Hofmann, Robert J J de Knegt, Stefan Zeuzem, Michael P P Manns, Bettina E E Hansen, Solko W W Schalm, Harry L A L Janssen
    posted to dm hcc hcv by jyuh on 2008-06-01 13:08:59 as **
  • Diagnosis and Treatment of Hepatocellular Carcinoma
    Gastroenterology, Vol. 134, No. 6. (May 2008), pp. 1752-1763.
    by Hashem B El-Serag, Jorge A Marrero, Lenhard Rudolph, Rajender K Reddy
    posted to hcc by jyuh on 2008-05-17 04:14:53 as **
  • DNA methylation in hepatocellular carcinoma.
    World journal of gastroenterology : WJG, Vol. 14, No. 11. (21 March 2008), pp. 1741-1748.
    by I Tischoff, A Tannapfe
    posted to hcc methylation by jyuh on 2008-05-14 16:56:27 as **
  • Dysregulation of growth factor signaling in human hepatocellular carcinoma.
    Oncogene, Vol. 25, No. 27. (26 June 2006), pp. 3787-3800.
    by K Breuhahn, T Longerich, P Schirmacher
    posted to hcc egfr by jyuh on 2008-04-27 16:12:14 as **
  • Surveillance for Hepatocellular Carcinoma in Patients with Cirrhosis Improves Outcome
    The American Journal of Medicine, Vol. 121, No. 2. (February 2008), pp. 119-126.
    by Richard T Stravitz, Douglas M Heuman, Nisha Chand, Richard K Sterling, Mitchell L Shiffman, Velimir A Luketic, Arun J Sanyal, Adil Habib, Anastasios A Mihas, Ho-Chong S Giles, Daniel G Maluf, Adrian H Cotterell, Marc P Posner, Robert A Fisher
    posted to hcc lc by jyuh on 2008-02-18 09:19:37 as **
  • Genetically distinct and clinically relevant classification of hepatocellular carcinoma: putative therapeutic targets.
    Gastroenterology, Vol. 133, No. 5. (November 2007), pp. 1475-1486.
    by H Katoh, H Ojima, A Kokubu, S Saito, T Kondo, T Kosuge, F Hosoda, I Imoto, J Inazawa, S Hirohashi, T Shibata
    posted to hcc by jyuh on 2008-01-25 02:04:10 as **
    • Puoi citare questa pagina come: http://www.citeulike.org/user/jyuh/tag/hcc

    RIS BibTeX